| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.26 | 0.1 |